Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2022 Results Earnings Conference Call March 21, 2023 4:30 PM ET Company Participants Nicole Leber - Investor Relations Associate Panna Sharma - Chief Executive Officer and President David Margrave - Chief Financial Officer and Secretary Kishor Bhatia - Chief Scientific Officer Conference Call Participants John Vandermosten - Zacks Research Michael King - EF Hutton Nicole Leber Welcome to our fourth quarter and full-year 2022 earnings call. I will be your host for today's ...